BRAF inhibitor treatment causes melanoma cells to shift how they produce energy
Friday, March 8, 2013 - 14:00
in Health & Medicine
BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism, new research shows. The findings suggest a strategy to improve the effectiveness of currently available targeted therapies.